Logo image
Se connecter
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries
Article de revue   Avec comité de lecture

Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries

Angela Loyse, Jessica Burry, Jennifer Cohn, Nathan Ford, Tom Chiller, Isabela Ribeiro, Sinata Koulla-Shiro, Janneth Mghamba, Angela Ramadhani, Rose Nyirenda, …
The Lancet infectious diseases, Vol.19(4), pp.e143-e147
04/2019
PMID: 30344084

Résumé

Africa - epidemiology Amphotericin B - agonists Amphotericin B - supply & distribution Amphotericin B - therapeutic use Antifungal Agents - economics Antifungal Agents - supply & distribution Antifungal Agents - therapeutic use Coinfection Cryptococcus neoformans - drug effects Cryptococcus neoformans - pathogenicity Developing Countries Disease Management Drug Administration Schedule Drug Therapy, Combination - economics Drug Therapy, Combination - methods Fluconazole - economics Fluconazole - supply & distribution Fluconazole - therapeutic use Flucytosine - economics Flucytosine - supply & distribution Flucytosine - therapeutic use Guidelines as Topic HIV Infections - mortality HIV Infections - pathology HIV Infections - virology Humans Income Meningitis, Cryptococcal - drug therapy Meningitis, Cryptococcal - microbiology Meningitis, Cryptococcal - mortality Meningitis, Cryptococcal - pathology Survival Analysis

Indicateurs

1 Consultations de la notice

Détails

Logo image